Puma Biotechnology Stock Price on December 16, 2024
| PBYI Stock | USD 2.92 0.08 2.67% |
Below is the normalized historical share price chart for Puma Biotechnology extending back to April 20, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Puma Biotechnology stands at 2.92, as last reported on the 18th of December 2024, with the highest price reaching 3.06 and the lowest price hitting 2.90 during the day.
If you're considering investing in Puma Stock, it is important to understand the factors that can impact its price. Puma Biotechnology appears to be unstable, given 3 months investment horizon. Puma Biotechnology maintains Sharpe Ratio (i.e., Efficiency) of 0.0691, which implies the firm had a 0.0691% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Puma Biotechnology, which you can use to evaluate the volatility of the company. Please evaluate Puma Biotechnology's Semi Deviation of 4.58, coefficient of variation of 1377.16, and Risk Adjusted Performance of 0.061 to confirm if our risk estimates are consistent with your expectations.
As of now, Puma Biotechnology's Total Stockholder Equity is decreasing as compared to previous years. The Puma Biotechnology's current Issuance Of Capital Stock is estimated to increase to about 3.3 M, while Common Stock Total Equity is projected to decrease to 4,275. . As of now, Puma Biotechnology's Price To Free Cash Flows Ratio is increasing as compared to previous years. The Puma Biotechnology's current Price Cash Flow Ratio is estimated to increase to 7.93, while Price Book Value Ratio is projected to decrease to 3.63. Puma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of April 2012 | 200 Day MA 3.6353 | 50 Day MA 2.9304 | Beta 1.08 |
Puma |
Sharpe Ratio = 0.0691
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PBYI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.5 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.31 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Puma Biotechnology is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Puma Biotechnology by adding it to a well-diversified portfolio.
Price Book 2.0716 | Enterprise Value Ebitda 2.7701 | Price Sales 0.5885 | Shares Float 32.5 M | Wall Street Target Price 4.3333 |
Related Headline
Revolution Medicines Headline on 16th of December 2024
Revolution Medicines SWOT analysis RAS inhibitor stock shows... by investing.com
Revolution Medicines SWOT analysis RAS inhibitor stock shows promise amid clinical trials
Puma Biotechnology Valuation on December 16, 2024
It is possible to determine the worth of Puma Biotechnology on a given historical date. On December 16, 2024 Puma was worth 2.88 at the beginning of the trading date compared to the closed value of 3.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Puma Biotechnology stock. Still, in general, we apply an absolute valuation method to find Puma Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Puma Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Puma Biotechnology's related companies.
| Open | High | Low | Close | Volume | |
| 2.94 | 2.94 | 2.82 | 2.88 | 299,796 | |
12/16/2024 | 2.88 | 3.12 | 2.88 | 3.00 | 391,648 |
| 3.00 | 3.06 | 2.90 | 2.92 | 374,486 |
| Backtest Puma Biotechnology | | | Puma Biotechnology History | | | Puma Biotechnology Valuation | Previous | Next |
Puma Biotechnology Trading Date Momentum on December 16, 2024
| On December 17 2024 Puma Biotechnology was traded for 2.92 at the closing time. The top price for the day was 3.06 and the lowest listed price was 2.90 . The trading volume for the day was 374.5 K. The trading history from December 17, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.67% . The trading delta at closing time against the current closing price is 0.00% . |
Puma Biotechnology Fundamentals Correlations and Trends
By evaluating Puma Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Puma Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Puma financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Puma Biotechnology Stock history
Puma Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Puma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Puma Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Puma Biotechnology stock prices may prove useful in developing a viable investing in Puma Biotechnology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 47.6 M | 32.7 M | |
| Net Income Applicable To Common Shares | 2.3 K | 2.4 K |
Puma Biotechnology Quarterly Net Working Capital |
|
Puma Biotechnology Stock Technical Analysis
Puma Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Puma Biotechnology Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
Puma Biotechnology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Puma Biotechnology December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Puma Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Puma Biotechnology shares will generate the highest return on investment. By undertsting and applying Puma Biotechnology stock market strength indicators, traders can identify Puma Biotechnology entry and exit signals to maximize returns
Puma Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Puma Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Puma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Puma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.061 | |||
| Jensen Alpha | 0.2192 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.0484 | |||
| Treynor Ratio | 0.1924 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |